Trials / Withdrawn
WithdrawnNCT06023368
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Marianne Hutti · Academic / Other
- Sex
- All
- Age
- 4 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to compare a sterile vapocoolant spray to EMLA cream in children with access ports. Participants will receive either the spray or cream prior to port access and rate pain on a scale. Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Num Vapocoolant Spray | Spray applied around port prior to access |
| DRUG | EMLA Cream | cream applied around the port prior to access |
Timeline
- Start date
- 2023-12-23
- Primary completion
- 2024-06-20
- Completion
- 2024-06-20
- First posted
- 2023-09-05
- Last updated
- 2024-11-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06023368. Inclusion in this directory is not an endorsement.